We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$715M
AUM Growth
+$45.2M
Cap. Flow
+$6.7M
Cap. Flow %
0.94%
Top 10 Hldgs %
30.36%
Holding
107
New
14
Increased
47
Reduced
34
Closed
5

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$6.31M
2
RPRX icon
Royalty Pharma
RPRX
+$4.55M
3
JNJ icon
Johnson & Johnson
JNJ
+$3.81M
4
CNA icon
CNA Financial
CNA
+$3.53M
5
HPE icon
Hewlett Packard
HPE
+$3.53M

Sector Composition

Rank Sector Weight
1 Technology 26.08%
2 Financials 19.43%
3 Healthcare 14.29%
4 Industrials 11.47%
5 Consumer Discretionary 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
26
SLB Ltd
SLB
$79.9B
$10.6M 1.49%
253,549
+5,681
+2% +$253K
AMAT icon
27
Applied Materials
AMAT
$391B
$10.6M 1.48%
52,284
+1,200
+2% +$246K
ULTA icon
28
Ulta Beauty
ULTA
$22.4B
$10.5M 1.47%
26,952
+4,908
+22% +$1.84M
AMT icon
29
American Tower
AMT
$81.9B
$9.81M 1.37%
42,171
-5,063
-11% -$1.12M
NOW icon
30
ServiceNow
NOW
$133B
$8.31M 1.16%
46,430
-8,740
-16% -$1.44M
CPRT icon
31
Copart
CPRT
$31.3B
$7.44M 1.04%
142,044
+79
+0.1% +$4.1K
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$139B
$7.33M 1.03%
15,751
+1,813
+13% +$871K
CASY icon
33
Casey's General Stores
CASY
$30.9B
$7.24M 1.01%
19,273
+8,833
+85% +$3.3M
ADBE icon
34
Adobe
ADBE
$109B
$6.94M 0.97%
13,402
+31
+0.2% +$17K
VEEV icon
35
Veeva Systems
VEEV
$40.3B
$6.84M 0.96%
32,571
-143
-0.4% -$28.3K
APH icon
36
Amphenol
APH
$194B
$6.78M 0.95%
104,027
-3
-0% -$194
TYL icon
37
Tyler Technologies
TYL
$14.4B
$6.35M 0.89%
10,877
-133
-1% -$74.9K
VRSK icon
38
Verisk Analytics
VRSK
$24.4B
$6.32M 0.88%
23,570
-75
-0.3% -$20.3K
SHW icon
39
Sherwin-Williams
SHW
$84.1B
$6.26M 0.88%
16,395
-105
-0.6% -$36.6K
V icon
40
Visa
V
$693B
$6.21M 0.87%
22,586
+736
+3% +$199K
KLAC icon
41
KLA
KLAC
$240B
$6.02M 0.84%
77,680
-540
-0.7% -$42.4K
SNPS icon
42
Synopsys
SNPS
$76.2B
$5.95M 0.83%
+11,759
New +$6.31M
AJG icon
43
Arthur J. Gallagher & Co
AJG
$67.6B
$5.87M 0.82%
20,849
-164
-0.8% -$46.3K
ORLY icon
44
O'Reilly Automotive
ORLY
$72.1B
$5.81M 0.81%
75,720
-27,765
-27% -$2.04M
DHR icon
45
Danaher
DHR
$154B
$5.54M 0.78%
19,921
-89
-0.4% -$23.6K
POOL icon
46
Pool Corp
POOL
$6.83B
$5.44M 0.76%
14,432
+304
+2% +$105K
MS icon
47
Morgan Stanley
MS
$336B
$5.05M 0.71%
48,487
+3,651
+8% +$368K
ENB icon
48
Enbridge
ENB
$110B
$5.04M 0.7%
123,991
+15,481
+14% +$596K
UPS icon
49
United Parcel Service
UPS
$86.8B
$4.66M 0.65%
34,176
+3,878
+13% +$509K
ABBV icon
50
AbbVie
ABBV
$468B
$4.26M 0.6%
21,564
+20
+0.1% +$3.73K

Similar funds

Robert Torray's Q3 2024 Portfolio in Review

As of Q3 2024, Robert Torray held 107 positions worth $715M, up 6.7% from $669M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Robert Torray's Q3 2024 filing shows 14 new, 47 increased, 34 reduced and 5 closed positions. Its largest new stake was Synopsys: 11,759 shares worth $5.95M. The largest sale was T. Rowe Price, an estimated $11.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Robert Torray's largest Q3 2024 buy was Synopsys: 11,759 shares worth $5.95M.
  • Robert Torray added most to Royalty Pharma in Q3 2024, an estimated $4.55M increase.
  • Robert Torray's biggest Q3 2024 reduction was Ansys, cutting an estimated $5.89M.
  • Robert Torray fully exited T. Rowe Price in Q3 2024, selling an estimated $11.1M.
  • Robert Torray's ten largest holdings make up 30% of its $715M portfolio in Q3 2024.
  • Robert Torray opened 14 new positions and closed 5 in Q3 2024.
  • Robert Torray's portfolio value rose 6.7% quarter-over-quarter to $715M.

Based on Torray Investment Partners's 13F filing for Q3 2024, filed 5 Nov 2024.